L&K Biomed Ltd. (KOSDAQ: 156100)
South Korea
· Delayed Price · Currency is KRW 6,870.00
+170.00 (2.54%)
Nov 15, 2024, 9:00 AM KST
L&K Biomed Revenue
L&K Biomed had revenue of 7.19B KRW in the quarter ending June 30, 2024, a decrease of -10.02%. This brings the company's revenue in the last twelve months to 30.50B, up 12.08% year-over-year. In the year 2023, L&K Biomed had annual revenue of 29.90B with 51.28% growth.
Revenue (ttm)
30.50B
Revenue Growth
+12.08%
P/S Ratio
4.39
Revenue / Employee
508.27M
Employees
60
Market Cap
136.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 29.90B | 10.14B | 51.28% |
| Dec 31, 2022 | 19.77B | 4.39B | 28.59% |
| Dec 31, 2021 | 15.37B | -3.98B | -20.58% |
| Dec 31, 2020 | 19.36B | -7.22B | -27.16% |
| Dec 31, 2019 | 26.57B | -4.75B | -15.16% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition